Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis

Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis

ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One...

Full description

Bibliographic Details
Main Authors: Luciana Prats Branco, Tarso Adoni, Samira Luisa Apostolos-Pereira, Joseph Bruno Bidin Brooks, Eber Castro Correa, Carlos Augusto Damasceno, Audred Cristina Biondo Eboni, Leticia Fezer, Paulo Diniz da Gama, Marcus Vinicius Magno Goncalves, Sidney Gomes, Anderson Kuntz Grzesiuk, Maria Fernanda Mendes, Rogerio Rizo Morales, Andre Muniz, Monica Fiuza Koncke Parolin, Maria Lucia Vellutini Pimentel, Marlise de Castro Ribeiro, Gutemberg Augusto Cruz dos Santos, Henry Koiti Sato, Simone Batista Scherpenhuijzen, Claudio Scorcine, Fabio Siquineli, Nise Alexandra de Carvalho Sousa, Daniel Lima Varela, Tereza Cristina Avila Winckler, Yara Dadalti Fragoso
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO)
Series:Arquivos de Neuro-Psiquiatria
Subjects:
multiple sclerosis
leukoencephalopathy, progressive multifocal
JC virus
natalizumab
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588&lng=en&tlng=en

Similar Items